EJ Roff Hilton, SL Hosking, T Betts - Seizure: European Journal of Epilepsy, 2004 - Elsevier Visual disturbances are a common side-effect of many antiepileptic drugs.
Non-specific retino- and neurotoxic visual abnormalities, that are often
reported with over-dosage and prolonged AED use, include diplopia, blurred ... Cited by 21 - Related articles - BL Direct - All 4 versions
Y Izumi, M Ishikawa, AM Benz, M Izumi, CF … - Epilepsia, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 13 - Related articles - BL Direct - All 4 versions
M Conway, RP Cubbidge, SL Hosking - Epilepsia, 2008 - interscience.wiley.com Methods: The sample comprised 31 patients (mean age 37.9 years; SD 14.4 years)
diagnosed with epilepsy and exposed to VGB. Each participant underwent standard
automated static visual field examination of the central visual field. ... Cited by 8 - Related articles - BL Direct - All 4 versions
SL Hosking, EJ Roff Hilton - Ophthalmic and Physiological Optics, 2002 - interscience.wiley.com AbstractVigabatrin is a GABA (γ-aminobutyric acid) transaminase inhibitor that
elicits an antiepileptic effect by enhancing inhibitory neurotransmission in the
brain. Vigabatrin has been previously associated with concentric peripheral ... Cited by 4 - Related articles - BL Direct - All 6 versions
Y Tseng, M Lan, S Lai, F Huang, J Tsai - Acta Neurologica Taiwanica, 2006 - neuro.org.tw From the 1Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung
Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan;
2Department of Ophthalmology, National Cheng Kung University Hospital; ... Cited by 1 - Related articles - View as HTML - BL Direct - All 3 versions
CR Ashby Jr, 2004 - freepatentsonline.com 1. Use of a drug that improves retinal perfusion for preparing a pharmaceutical
composition for ameliorating visual field defects associated with concurrent or
subsequent administration of a GABAergic drug to a mammal in need thereof. Related articles - All 2 versions